Related references
Note: Only part of the references are listed.Pelvic organ prolapse following hysterectomy on benign indication: a nationwide, nulliparous cohort study
Karen R. Husby et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)
Should the risk for uterine cancer influence decision making for prophylactic hysterectomy in BRCA1/2 mutated patients- a systematic review and meta-analysis
Chen Nahshon et al.
GYNECOLOGIC ONCOLOGY (2021)
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021
Mary B. Daly et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer
Maria Teresa Vietri et al.
MEDICAL ONCOLOGY (2021)
Serous endometrial intraepithelial carcinoma: A clinico-pathological study of 48 cases and its association with endometrial polyps - A tertiary care oncology centre experience
Subhash Yadav et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2021)
BRCA1 and BRCA2 pathogenic variant carriers and endometrial cancer risk: A cohort study
Sarah J. Kitson et al.
EUROPEAN JOURNAL OF CANCER (2020)
Risk-Reducing Bilateral Salpingo-Oophorectomy for BRCA Mutation Carriers and Hormonal Replacement Therapy: If It Should Rain, Better a Drizzle than a Storm
Maria Luisa Gasparri et al.
MEDICINA-LITHUANIA (2019)
Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers
Yael Laitman et al.
CANCER (2019)
Impact of BRCA mutations on outcomes among patients with serous endometrial cancer
Yfat Kadan et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer
Chunling Hu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
Stephanie M. de Boer et al.
LANCET ONCOLOGY (2018)
Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers
Joanne Kotsopoulos et al.
JAMA ONCOLOGY (2018)
Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers
Y. C. Lee et al.
EUROPEAN JOURNAL OF CANCER (2017)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience
Giorgio Bogani et al.
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY (2017)
Risk of Serous Endometrial Carcinoma in Women With Pathogenic BRCA1/2 Variant After Risk-Reducing Salpingo-Oophorectomy
Claire Saule et al.
JNCI-Journal of the National Cancer Institute (2017)
Risk of Serous Endometrial Carcinoma in Women With Pathogenic BRCA1/2 Variant After Risk-Reducing Salpingo-Oophorectomy
Claire Saule et al.
JNCI-Journal of the National Cancer Institute (2017)
Hormone therapy after prophylactic risk-reducing bilateral salpingo-oophorectomy in women who have BRCA gene mutation
F. Guidozzi
CLIMACTERIC (2016)
Metachronous serous endometrial intraepithelial carcinoma and serous peritoneal carcinoma: analysis of probable independent lesions
Mitsuko Furuya et al.
DIAGNOSTIC PATHOLOGY (2016)
Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers
Mae Zakhour et al.
GYNECOLOGIC ONCOLOGY (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations
Catherine A. Shu et al.
JAMA ONCOLOGY (2016)
Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study
Yakir Segev et al.
FAMILIAL CANCER (2015)
Endometrial Cancers in Mutation Carriers From Hereditary Breast Ovarian Cancer Syndrome Kindreds Report From the Creighton University Hereditary Cancer Registry With Review of the Implications
Murray Joseph Casey et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2015)
Characterization of Precursor Lesions in the Endometrium and Fallopian Tube Epithelium of Early-Stage Uterine Serous Carcinoma
Mary C. Tolcher et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2015)
Alteration in PI3K/mTOR, MAPK pathways and Her2 expression/amplification is more frequent in uterine serous carcinoma than ovarian serous carcinoma
Haider Mahdi et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers
Helen Cavanagh et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2015)
BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma
Kathryn P. Pennington et al.
CANCER (2013)
The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: An international prospective cohort study
Yakir Segev et al.
GYNECOLOGIC ONCOLOGY (2013)
Endometrium is not the primary site of origin of pelvic high-grade serous carcinoma in BRCA1 or BRCA2 mutation carriers
Welmoed Reitsma et al.
MODERN PATHOLOGY (2013)
A case of minimal uterine serous carcinoma with distant lymph node metastasis without peritoneal dissemination
Kouichiro Kawano et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2011)
The rate of the predominant Jewish mutations in the BRCA1, BRCA2, MSH2 and MSH6 genes in unselected Jewish endometrial cancer patients
Frida Barak et al.
GYNECOLOGIC ONCOLOGY (2010)
BRCA1/2 Germline Mutations in Jewish Patients With Uterine Serous Carcinoma
Ilan Bruchim et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
Susan M. Domchek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Minimal Uterine Serous Carcinoma With Extrauterine Tumor of Identical Morphology: An Immunohistochemical Study of 13 Cases
Zhijie Yan et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Primary Fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction
Michael J. Callahan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations.: A prospective study
Mario E. Beiner et al.
GYNECOLOGIC ONCOLOGY (2007)
High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma
T. Biron-Shental et al.
EJSO (2006)
Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist
Aleksandra Jovanovic Poole et al.
SCIENCE (2006)
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation
Amy Finch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: Role of serial sectioning in the detection of occult malignancy
CB Powell et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
BRCA germline mutations in Jewish women with uterine serous papillary carcinoma
O Lavie et al.
GYNECOLOGIC ONCOLOGY (2004)
Pathologic findings in prophylactic oophorectomy specimens in high-risk women
K Leeper et al.
GYNECOLOGIC ONCOLOGY (2002)
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2 -: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
MC King et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Early uterine serous carcinoma: Clonal origin of extrauterine disease
RN Baergen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2001)
Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?
R Goshen et al.
GYNECOLOGIC ONCOLOGY (2000)
Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer
A Eisen et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
